A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23031855
Abstract: Liver cancer has relatively few early symptoms and is usually diagnosed in the advanced stage. Sorafenib is the only first-line anticancer drug approved by the Food and Drug Administration (FDA) for advanced HCC; however, its… read more here.
Keywords: hcc tissues; critical yap; hcc; malignancy hcc ... See more keywords